Background D-3-aminoisobutyrate, an intermediary product of thymine, is converted to 2-methyl-3-oxopropanoate using pyruvate as an amino acceptor by D-3-aminoisobutyrate-pyruvate aminotransferase (D-AIB AT; EC 2.6.1.40). A large amount of D-AIB AT is distributed in the kidney and liver; ...
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate CAS NO: 2346620-55-9 分子量: 暂无数据 EC NO: 暂无数据 规格: 暂无数据 包装: 暂无数据
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate,USD,100/KG,cas No:2346620-55-9,Formula:C16H23N3O7,purity:99%min- Hangzhou Dingyan Chem Co.,Ltd
The overall efficiency of the coupling between transport of α-aminoisobutyrate and the entry of Na + in Ehrlich cells has previously been determined to be 8–10%. It was concluded that the efficiency is grossly inadequate to account for... E HEINZ,P GECK - 《Biochimica Et Biophysica Acta》...
产品类别: 中间体/医药中间体 英文名称: ((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate CAS NO: 2492423-29-5 分子量: 暂无数据 EC NO:
产品类别: 英文名称: ((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate CAS NO: 2346620-55-9 分子量: 暂无数据 EC NO: 暂无数据 规格: 暂无数据 ...
英文别名:((2R,3S,4R,5R)-3,4-dihydroxy-5-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methylisobutyrate;EIDD-2801(EIDD2801);EIDD-2801;Tube994;Molnupiravir(MK-4482);Uridine,4-oxime,5'-(2-methylpropanoate);β-D-N4hydroxycytidine-5'-isopropylester;Mo...
产品类别: 医药与生物化工 英文名称: EIDD-2801 CAS NO: 2349386-89-4 分子量: 暂无数据 EC NO: 暂无数据 规格: 暂无数据 包装: 暂无数据 结构式: 暂无数据 立即询盘1340421267213979891222 产品介绍 暂无产品详细介绍 品名:莫那比拉韦 用途:暂无数据
莫那比拉韦 MOLNUPIRAVIR(核苷抑制剂EIDD-2801/MK4482);(2R,3S,4R,5R)-3,4-二羟基-5-[4-(羟基氨基)-2-恶吡啶-1-基]恶唑烷-2-基]甲基2-甲基丙酸盐 2349386-89-4 C13H19N3O7 329.31 EIDD-2801是核糖核苷类似物EIDD-1931的口服生物可利用的前药。EIDD-2801具有针对流感病毒和多种冠状病毒(例如SARS-...
EIDD-2801是核糖核苷类似物EIDD-1931的口服生物可利用的前药。EIDD-2801具有针对流感病毒和多种冠状病毒(例如SARS-ChemicalbookCoV-2,MERS-CoV,SARS-CoV)的广谱抗病毒活性。EIDD-2801具有治疗COVID-19以及季节性和大流行性流感的潜力。 品名:莫那比拉韦